TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | -5 | -7 | 7 | 27 | 79 | 179 | 47 |
| P | %wins | 0 | 0 | 67 | 100 | 100 | 100 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/12 16:40 | 9/13/12 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Gao David | F4 | DO | CEO | P | 45 | 8.93 | 0 | 5 | 71 | 12 | D | 0 | 23 | 4 | 3 | -7 | -2 | 7 | 8 | -1 | -3 | -1 | 60 | 190 | 156 | |
5/15/12 07:59 | 5/14/12 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Gao David | F4 | DO | CEO | P | 26 | 9.50 | 0 | 3 | 63 | 7 | I | -36 | -39 | 17 | -14 | -9 | -10 | -2 | -7 | -3 | -4 | 18 | 14 | 31 | 209 | |
5/14/12 13:11 | 5/11/12 | CBPO | China Biologic Products, Inc. | Health | BioPrd | Biological Products, (No Diag | Gao David | F4 | DO | CEO | P.d | 41 | 9.50 | 0 | 4 | New | 4 | I | -30 | -32 | 34 | -2 | 3 | 1 | 6 | 9 | -12 | -15 | 5 | 8 | 15 | 171 | |
8/17/09 08:56 | 8/13/09 | BJGP | Bmp Sunstone Corp | DE | Retail | WhDrg | Drugs, Proprietaries & Druggi | Gao David | PA | DO | CEO | P | 39 | 3.93 | 0 | 10 | 1 | 711 | D | ||||||||||||||
5/27/08 16:54 | 5/22/08 | BJGP | Bmp Sunstone Corp | Retail | WhDrg | Drugs, Proprietaries & Druggi | Gao David | PA | DO | CEO | P | 71 | 7.08 | 0 | 10 | New | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |